Geode Capital Management, LLC Medicenna Therapeutics Corp. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
$1.26 - $1.92 $8,203 - $12,501
6,511 Added 23.56%
34,144 $43,000
Q3 2021

Nov 12, 2021
BUY
$1.91 - $3.05 $9,926 - $15,850
5,197 Added 23.16%
27,633 $76,000
Q2 2021

Aug 13, 2021
BUY
$2.97 - $4.28 $7,941 - $11,444
2,674 Added 13.53%
22,436 $67,000
Q1 2021

May 12, 2021
BUY
$3.5 - $4.56 $69,167 - $90,114
19,762 New
19,762 $80,000

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email